Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Thorbald van Hall

40PUBLICATIONS

123CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (40)

Sort by Publication Date:

|Nov 13, 2025

Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody binding.

Anneloes van der Plas-van Duijn, Levi M T Winkelman, Claire Lensen

|May 28, 2025

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study.

Mitchell Emmers, Marij J P Welters, Michelle V Dietz

|Jan 12, 2025

Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy.

Jim Middelburg, Gaby Schaap, Marjolein Sluijter

|Jan 09, 2024

Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen

|Jan 03, 2024

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors.

Jim Middelburg, Marjolein Sluijter, Gaby Schaap

|Oct 29, 2023

Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models.

Gerwin Gerhard Wemke Sandker, Jim Middelburg, Evienne Wilbrink

Pageof 7

Frequent Collaborators

14 joint publications

Sjoerd H van der Burg

6 joint publications

Christianne Groeneveldt

5 joint publications

Diana J M van den Wollenberg

5 joint publications

Nadine van Montfoort

5 joint publications

Rob C Hoeben

4 joint publications

Jim Middelburg

4 joint publications

Ramon Arens

4 joint publications

Jan Willem Kleinovink

3 joint publications

Janine Schuurman

3 joint publications

Hreinn Benonisson

Frequent Collaborators

14 joint publications

Sjoerd H van der Burg

6 joint publications

Christianne Groeneveldt

5 joint publications

Diana J M van den Wollenberg

5 joint publications

Nadine van Montfoort

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos